External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder

Fritsche, H. M. and May, M. and Burger, M. and Nuhn, P. and Otto, W. and Buchner, A. and Bolenz, C. and Herrmann, E. and Ellinger, J. and Hoefner, T. and Tilki, D. and Roigas, J. and Zacharias, M. and Trojan, L. and Haferkamp, A. and Gilfrich, C. and Hertle, L. and Hohenfellner, M. and Mueller, S. C. and Stief, C. G. and Wieland, W. F. and Bastian, P. J. (2012) External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder. EUROPEAN UROLOGY SUPPLEMENTS, 11 (1). e872-e872a. ISSN 1569-9056

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Petra Gürster
Date Deposited: 11 May 2020 06:12
Last Modified: 11 May 2020 06:12
URI: https://pred.uni-regensburg.de/id/eprint/19259

Actions (login required)

View Item View Item